Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
-
- Norihiro Kokudo
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Nobuyuki Takemura
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Kiyoshi Hasegawa
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Tadatoshi Takayama
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Shoji Kubo
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Mitsuo Shimada
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Hiroaki Nagano
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Etsuro Hatano
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Namiki Izumi
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Shuichi Kaneko
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Masatoshi Kudo
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Hiroko Iijima
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takuya Genda
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Ryosuke Tateishi
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takuji Torimura
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Hiroshi Igaki
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Satoshi Kobayashi
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Hideyuki Sakurai
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takamichi Murakami
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takeyuki Watadani
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Yutaka Matsuyama
- The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
抄録
<jats:p>The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic, and treatment algorithms.</jats:p>
収録刊行物
-
- Hepatology Research
-
Hepatology Research 49 (10), 1109-1113, 2019-09-06
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361131420431898624
-
- ISSN
- 1872034X
- 13866346
-
- データソース種別
-
- Crossref
- KAKEN